Setting the Bar for Early Phase Innovative Projects in the Pharmaceutical Industry
- Lecturer(s): Dr. Inbal Landsberg, Dexcel Pharma
- Location: TAU
- Date: Thursday, 14 September 2017
Published in
Related items
-
EXPERT PANEL - Personalized attention and cognitive control training for children with Autism: A potential booster for everyday functioning
-
Personalized attention and cognitive control training for children with Autism: A potential booster for everyday functioning
-
Neuroplasticity in developmental disorders: the specific case of dyslexia
-
Behind the smokescreen of medical cannabis
-
Activity-dependent neuroprotective protein (ADNP) deficiency models synaptic and developmental phenotypes of autism-like syndrome: Toward innovative drug development